These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23589951)

  • 1. Role of plasma exchange in the treatment of myeloma nephropathy: experience of one institution and systematic review.
    Kourelis TV; Manola A; Moustakakis MN; Bilgrami SF
    Conn Med; 2013 Mar; 77(3):147-51. PubMed ID: 23589951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmapheresis in myeloma cast nephropathy.
    Chapdelaine I; Madore F
    Clin Nephrol; 2013 Jan; 79(1):72-7. PubMed ID: 23249872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraprotein-Related Kidney Disease: Evaluation and Treatment of Myeloma Cast Nephropathy.
    Finkel KW; Cohen EP; Shirali A; Abudayyeh A;
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2273-2279. PubMed ID: 27526708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic apheresis for the renal complications of multiple myeloma and the dysglobulinemias.
    Kaplan AA
    Ther Apher; 2001 Jun; 5(3):171-5. PubMed ID: 11467752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal treatment of cast nephropathy.
    Gakhar B; Kobrin S; Berns JS
    Semin Dial; 2011; 24(1):9-11. PubMed ID: 21324000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of plasmapheresis in immunological kidney diseases. Experience from 1050 completed plasmapheresis treatment sessions].
    Haris A; Arányi J; Braunitzer H; Kálmán E; Merán Z; Soltész M; Polner K
    Orv Hetil; 2011 Jul; 152(28):1110-9. PubMed ID: 21712172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of therapeutic plasma exchange for the treatment of patients with multiple myeloma cast nephropathy.
    Dima D; Goel U; Sannareddy A; Ibeh N; Ullah F; Afrough A; Mazzoni S; Mehdi A; Rudoni J; Raza S; De Simone N; Williams L; Khan A; Rashid A; Rice M; Ricci K; Samaras C; Valent J; Anderson LD; Anwer F; Kaur G; Khouri J
    Hematol Oncol; 2024 Jul; 42(4):e3293. PubMed ID: 38872511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of plasmapheresis in symptomatic hyperviscosity and cast nephropathy: A Multicenter Experience in Turkey.
    Kalpakci Y; Hacibekiroglu T; Darcin T; AkgunCagliyan G; Cakar MK; Hacioglu SK; Ekinci O; Korkmaz S; Albayrak M; Dal MS; Dogan A; Ulas T; Eser B; Altuntas F
    Transfus Apher Sci; 2021 Oct; 60(5):103244. PubMed ID: 34462219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approach to acute renal failure with multiple myeloma: role of plasmapheresis.
    El-Achkar TM; Sharfuddin AA; Dominguez J
    Ther Apher Dial; 2005 Oct; 9(5):417-22. PubMed ID: 16202018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmapheresis in a Patient with Sarcoidosis Who Developed Multiple Myeloma and Massive Free Kappa Light Chains Nephropathy.
    Markel A; Habashe N; Aviv A; Monich O; Elmalah I; Marei N; Tovbin D
    Isr Med Assoc J; 2018 May; 20(5):324-326. PubMed ID: 29761682
    [No Abstract]   [Full Text] [Related]  

  • 11. Myeloma cast nephropathy presenting as acute onset bilateral reversible hearing loss.
    Ahmad M
    Int Urol Nephrol; 2007; 39(3):963-5. PubMed ID: 17554633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal disease in multiple myeloma].
    Hiromura K; Nojima Y
    Nihon Rinsho; 2007 Dec; 65(12):2229-34. PubMed ID: 18069265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing renal complications in multiple myeloma.
    Fotiou D; Dimopoulos MA; Kastritis E
    Expert Rev Hematol; 2016 Sep; 9(9):839-50. PubMed ID: 27426872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of continuous venovenous hemofiltration for acute renal failure due to multiple myeloma cast nephropathy.
    Mehta S; Shtaynberg N; Goldman M; Asti D; Kiroycheva M; Pepe J
    Hematology; 2012 Jul; 17(4):229-31. PubMed ID: 22889516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains.
    Leung N; Gertz MA; Zeldenrust SR; Rajkumar SV; Dispenzieri A; Fervenza FC; Kumar S; Lacy MQ; Lust JA; Greipp PR; Witzig TE; Hayman SR; Russell SJ; Kyle RA; Winters JL
    Kidney Int; 2008 Jun; 73(11):1282-8. PubMed ID: 18385667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasmapheresis in the therapy of the hyperosmolar syndrome in patients with myelomatous nephropathy].
    Borisov AV; Butrov AV; Moroz VA
    Ter Arkh; 1991; 63(7):101-5. PubMed ID: 1788784
    [No Abstract]   [Full Text] [Related]  

  • 17. [Plasmapheresis treatment in multiple myeloma with kidney insufficiency].
    Blumberg A; Bürgi W; Marti HR
    Schweiz Med Wochenschr; 1983 Mar; 113(11):398-402. PubMed ID: 6844898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasmapheresis in the treatment of chronic secondary nephropathy of various etiologies].
    Bazzato G; Lucatello S; Tingani A; Landini S; Coli U; Fracasso A; Morachiello P; Fabris G
    Minerva Nefrol; 1981; 28(3):235-41. PubMed ID: 6460206
    [No Abstract]   [Full Text] [Related]  

  • 19. Approach to acute renal failure in biopsy proven myeloma cast nephropathy: is there still a role for plasmapheresis?
    Pillon L; Sweeting RS; Arora A; Notkin A; Ballard HS; Wieczorek RL; Leung N
    Kidney Int; 2008 Oct; 74(7):956-61. PubMed ID: 18418353
    [No Abstract]   [Full Text] [Related]  

  • 20. [Research Advances in Treatment of Myeloma Nephropathy-Review].
    Zhang XP; Xia ZY; Chen BA; Gao C
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):613-616. PubMed ID: 28446322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.